CN102335466A - Blood perfusion device for treating hypertension - Google Patents
Blood perfusion device for treating hypertension Download PDFInfo
- Publication number
- CN102335466A CN102335466A CN2010102374557A CN201010237455A CN102335466A CN 102335466 A CN102335466 A CN 102335466A CN 2010102374557 A CN2010102374557 A CN 2010102374557A CN 201010237455 A CN201010237455 A CN 201010237455A CN 102335466 A CN102335466 A CN 102335466A
- Authority
- CN
- China
- Prior art keywords
- perfusion device
- blood perfusion
- average pore
- adsorbent resin
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a blood perfusion device for treating hypertension. The blood perfusion device is composed of a tank body and adsorbent resin sealed and filled in the tank body, wherein the adsorbent resin is styrene-divinylbenzene polymer microspheres with the specific physical parameters as follows: specific surface area of 1025 m<2>/g weight +/- 10%, average pore diameter of 2.389 nm +/- 10% and average pore volume of 0.528 mL/g weight +/- 10%.
Description
Technical field under the invention:
The invention belongs to medical apparatus and instruments, especially for the medical apparatus and instruments of blood purification treatment.
The background of invention technology:
Adopting blood perfusion device to purify the blood is the medical new technique that developed recently gets up.The blood perfusion device of using clinically at present that has salvage drug to poison.The blood perfusion device of opiates poisonous substance excessive in the quick removing human body was once invented by applicant unit before the several years.But at the blood perfusion device product that does not still have aspect the treatment vascular hypertension to be suitable for.
The content of invention:
The objective of the invention is to propose a kind of blood perfusion device product technology scheme of treating vascular hypertension, use the blood purification mode and remove vascular hypertension morbid substance in the blood, with developing treatment vascular hypertension new way.
The technical scheme of blood perfusion device of the present invention comprises that tank body and sealing are filled in a jar intravital adsorbent resin and constitute, and employed adsorbent resin is the SDEB styrene diethylenebenzene polymer microballoon, its
Concrete physical parameter is:
Specific surface area: 1025 meters squared per gram are heavy, and ± 10%;
Average pore size: 2.389 nanometers, ± 10%;
Average pore volume: 0.528 milliliter/grammes per square metre, ± 10%.
The outstanding substantive distinguishing features of blood perfusion device of the present invention is the characterization of adsorption that utilizes resin, adsorbs the morbid substance of vascular hypertension pointedly, and when treatment finishes, takes out of the morbid substance separation external; Opened up and be different from the new medicinal approaches that all adopt hypertension therapy disease.
Blood perfusion device obvious improvement of the present invention is that the clinical treatment mode is simple and easy to do, and come into force fast, evident in efficacy.
Embodiments of the invention are following;
Embodiment 1: patient Wang 59 years old, suffer from essential hypertension disease, and to take medicine throughout the year, blood pressure maintains 90/150.
Adopt blood perfusion device of the present invention once through treatment in 120 minutes.Just have in the operation process from head to foot and feel easily, brains is also regained consciousness gradually and is no longer fainted.Clinical follow is so far above 1 year.Blood pressure drops to 80/120 immediately from postoperative, no longer takes any antihypertensive drugs and keeps so far.Winter, blood pressure remained on 80/120, and summer, blood pressure remained on 70/110.The health each side has the sensation of becoming better and better.
Embodiment 2: patient Wang 65 years old, suffer from secondary hypertension, and with hyperthyroidism.Take medicine, blood pressure maintains 110/180 throughout the year; And often fluctuate round the clock.
Adopt blood perfusion device of the present invention once through treatment in 120 minutes.Feel promptly in the operation process that brains is clear-headed, light from head to foot gradually.Postoperative blood pressure promptly drops to 90/140.Clinical follow after one month symptom have repeatedly, show as the blood pressure instability that fluctuates up and down.The patient adheres to not taking medicine according to doctor's advice.Postoperative one month was to do for the second time clinically, still used blood perfusion device of the present invention to treat, and treatment time is 90 minutes.The clinical follow blood pressure is gradually steady, and four months so far, the patient did not take medicine blood pressure stabilization at 90/130-140; The symptom of hyperthyroidism also obviously alleviates.
Embodiment 3: patient's car 55 years old, suffer from vascular hypertension, and follow hyperlipidemia.Take medicine, blood pressure maintains 90/160 throughout the year.
Adopt blood perfusion device of the present invention once through treatment in 120 minutes.Feel promptly in the operation process that brains is clear-headed, light from head to foot gradually.Postoperative blood pressure promptly drops to 70/110.The hyperlipidemia index drops to normally.About so far 1 year of clinical follow.Blood pressure remains at 70/110.
Claims (1)
1. a blood perfusion device of treating vascular hypertension is filled in a jar intravital adsorbent resin by tank body and sealing and constitutes, and it is characterized in that:
Employed adsorbent resin is the SDEB styrene diethylenebenzene polymer microballoon, and its concrete physical parameter is:
Specific surface area: 1025 meters squared per gram are heavy, and ± 10%;
Average pore size: 2.389 nanometers, ± 10%;
Average pore volume: 0.528 milliliter/grammes per square metre, ± 10%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102374557A CN102335466A (en) | 2010-07-27 | 2010-07-27 | Blood perfusion device for treating hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102374557A CN102335466A (en) | 2010-07-27 | 2010-07-27 | Blood perfusion device for treating hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102335466A true CN102335466A (en) | 2012-02-01 |
Family
ID=45511563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102374557A Pending CN102335466A (en) | 2010-07-27 | 2010-07-27 | Blood perfusion device for treating hypertension |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102335466A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103357383A (en) * | 2012-03-31 | 2013-10-23 | 重庆赛英思医疗器械股份有限公司 | Macroporous adsorbent resin and application |
| CN103357073A (en) * | 2012-03-31 | 2013-10-23 | 重庆赛英思医疗器械股份有限公司 | High-molecular material hemoperfusion apparatus for treating metabolic hypertension patient |
| CN104857015A (en) * | 2013-08-12 | 2015-08-26 | 天津市阳权医疗器械有限公司 | Styrene type novel-structure adsorption resin for de-addiction and detoxification |
-
2010
- 2010-07-27 CN CN2010102374557A patent/CN102335466A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103357383A (en) * | 2012-03-31 | 2013-10-23 | 重庆赛英思医疗器械股份有限公司 | Macroporous adsorbent resin and application |
| CN103357073A (en) * | 2012-03-31 | 2013-10-23 | 重庆赛英思医疗器械股份有限公司 | High-molecular material hemoperfusion apparatus for treating metabolic hypertension patient |
| CN104857015A (en) * | 2013-08-12 | 2015-08-26 | 天津市阳权医疗器械有限公司 | Styrene type novel-structure adsorption resin for de-addiction and detoxification |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20140029482A (en) | Ropinirole-containing adhesive skin patch and packaged product thereof | |
| CN102335466A (en) | Blood perfusion device for treating hypertension | |
| CN102335465A (en) | Blood perfusion device for treating uremia | |
| CN103251695B (en) | Zhuifeng huaci wine for treating arthromyodynia and preparation method thereof | |
| CN104800774A (en) | Compound for improving sleeping quality and application thereof | |
| Parker et al. | Safety of combined use of local anesthetic infiltration and reinfusion drains in total knee arthroplasty | |
| CN101194987B (en) | Powder medicament for treating recurrent mouth ulcer | |
| Webster et al. | The long-term safety of subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic nonmalignant pain | |
| CN203183173U (en) | Multipurpose safe wheelchair | |
| CN102552405B (en) | Method for preparing medicinal composition for perianal anaesthetic analgesia of postoperation | |
| CN102068511A (en) | External medicament for treating lumbar vertebral disc protrusion | |
| CN1246018C (en) | Chinese medicine for treating hyperosteogeny and osteophyte | |
| CN110478441A (en) | A kind of Chinese medicine and preparation method thereof for treating the protrasion of the lumbar intervertebral disci | |
| CN103393906A (en) | Cold preventing tincture | |
| CN102204966B (en) | Traditional Chinese medicine liniment for external use for relaxing muscles and tendons and alleviating pain | |
| JP6386571B2 (en) | Orally administered pharmaceutical adsorbent with increased strength | |
| CN1965860A (en) | Acupoints applied medicament for treating insomnia and preparation process thereof | |
| CN1201791C (en) | Wind dispelling and pain relieving ointment | |
| Kia et al. | Epidural blood patch as treatment for CSF leak during spinal cord stimulator implantation | |
| CN102125612A (en) | Chinese medicinal preparation for treating acute lumbar sprain | |
| Malavaud et al. | Visual hallucinations at the onset of tolterodine treatment in a patient with a high-level spinal cord injury | |
| CA2848231C (en) | New use of melatonine | |
| CN1965969A (en) | Externally applied medicament for treating ostealgia and hyperosteogeny and method for preparing same | |
| CN108815484B (en) | Pharmaceutical composition for treating Parkinson's disease and application | |
| CN100342864C (en) | Medicine for treating chronic hemorrhoids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120201 |